在糖尿病,超脂血症子的后肢缺血模型中,跨膜干因子纳米盘增强了后肢血管化
Eri Takematsu1,2, Miles Massidda1, Gretchen Howe3
1Department of Biomedical Engineering, University of Texas at Austin, 1 University Station, BME 5.202D, C0800, Austin, TX, 78712, USA.
Scientific reports
|January 29, 2024
概括
在纳米盘中输送的跨膜干细胞因子 (SCF) 在外周缺血症的子模型中成功促进了血管生长. 这种新疗法在治疗血管疾病方面表现有前途,没有有毒副作用.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 血管生物学 血管生物学
背景情况:
- 重血管化疗法旨在恢复血液流向缺血组织,这对于治疗诸如外周动脉疾病等疾病至关重要.
- 之前的干细胞因子 (SCF) 疗法因有毒副作用而面临局限性,例如巨细胞激活.
- 在脂质纳米盘中输送的新型跨膜SCF (tmSCF) 已经显示出安全有效的重血管化的潜力.
研究的目的:
- 评估tmSCF纳米光盘在后肢缺血的先进子模型中的有效性和安全性.
- 评估tmSCF纳米光盘在一种对传统血管新生疗法耐药的模型中的治疗潜力.
主要方法:
- 饮食诱导的超脂血症和糖尿病的子经历了诱导的后肢缺血.
- tmSCF纳米盘或对照溶液通过酸盐凝局部输送到缺血肢体中.
- 使用血管学量化血管性,并在八周后通过组织学分析评估血管密度.
主要成果:
- 与对照组相比,tmSCF纳米盘治疗导致血管性显著增加,通过血管学确认.
- 组织学检查显示,治疗子的缺血肌肉中存在更多的小型和大型血管.
- 在tmSCF纳米盘治疗组中没有观察到炎症或巨细胞激活的情况.
结论:
- tmSCF纳米盘显示出在促进外周缺血症的重血管化方面具有显著的治疗潜力.
- 这种基于纳米盘的新型疗法为以前的SCF治疗提供了一个有希望的,安全的替代方案.
- 这些发现支持tmSCF纳米光盘在血管疾病的临床应用方面取得进展.
相关概念视频
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...